tradingkey.logo

DarioHealth Corp <DRIO.OQ> expected to post a loss of 33 cents a share - Earnings Preview

ReutersMar 7, 2025 12:56 PM
  • DarioHealth Corp DRIO.OQ DRIO.O is expected to show a rise in quarterly revenue when it reports results on March 10 for the period ending December 31 2024

  • The New York City-based company is expected to report a 104.3% increase in revenue to $7.387 million from $3.62 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for DarioHealth Corp is for a loss of 33 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for DarioHealth Corp is $3.50​, above​ its last closing price of $0.73. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.28

-0.27

-0.25

Beat

8.5

Jun. 30 2024

-0.55

-0.55

-0.08

Beat

85.6

Mar. 31 2024

-0.48

-0.40

-0.20

Beat

50.6​

Dec. 31 2023

-0.54

-0.55

-0.50

Beat

9.6

​​Sep. 30 2023

-0.48

-0.46

-0.49

Missed

-6.5

Jun. 30 2023

-0.57

-0.52

-0.58

Missed

-11.1​

Mar. 31 2023

-0.49

-0.50

-0.45

Beat

9.6

Dec. 31 2022

-0.56

-0.65

-0.51

Beat

21.8

This summary was machine generated March 7 at 12:56 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI